Collegium Pharmaceutical (COLL) Interest & Investment Income (2016 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Interest & Investment Income of $3.7 million for Q1 2026, up 66.56% year-over-year from $2.2 million in Q1 2025, and up 3.96% quarter-over-quarter from $3.6 million in Q4 2025.
Collegium Pharmaceutical (COLL) Interest & Investment Income (2016 - 2026) Analysis & Trends
Collegium Pharmaceutical's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $3.7 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 66.56% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $12.8 million (up 9.01% YoY), while the FY2025 annual figure was $11.3 million, down 19.23% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $3.7 million, up from $3.6 million in the prior quarter.
- The five-year high for Interest & Investment Income was $4.5 million in Q3 2023, with the low at $4000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $3.1 million (2025), against an average of $2.7 million.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income surged 80440.0% in 2023, then slumped 57.89% in 2024.
- Collegium Pharmaceutical's Interest & Investment Income stood at $1.0 million in 2022, then surged by 318.99% to $4.3 million in 2023, then plunged by 57.89% to $1.8 million in 2024, then surged by 96.74% to $3.6 million in 2025, then climbed by 3.96% to $3.7 million in 2026.
- Business Quant data shows COLL's Interest & Investment Income at $3.7 million in Q1 2026, $3.6 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Collegium Pharmaceutical | 887.15 Mn | 737.84 Mn | 110.29 Mn | 2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.29 Mn |
| Mar 31, 2026 | 3.71 Mn |
| Dec 31, 2025 | 3.57 Mn |
| Sep 30, 2025 | 3.12 Mn |
| Jun 30, 2025 | 2.38 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 4.40 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 4.30 Mn |
| Sep 30, 2023 | 4.54 Mn |
| Jun 30, 2023 | 4.03 Mn |
| Mar 31, 2023 | 2.75 Mn |
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 11,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |